Sonye Danoff, MD

Dr. Lee is a specialist in Interventional Pulmonary and serves as the Wang Interventional Pulmonary Fellowship Director. His areas of clinical expertise include interventional pulmonology, pleural disease, minimal invasive diagnostics and lung cancer at Johns Hopkins. He also has extensive experience in the minimally invasive management of malignant airway obstruction, complex airway management and difficulty airways. In addition, he specializes in the diagnosis and management of pleural diseases and symptom relief with minimally invasive procedures. He is a fellow of the American College of Chest Physicians and the Johns Hopkins Master of Education for Health Professionals.

Matthew Ippolito, M.D., Ph.D. is an Associate Professor of Medicine and the Director of Clinical Epidemiology for the Southern and Central Africa International Centers of Excellence for Malaria Research (ICEMR). He received his A.B. from Dartmouth College and his M.D. from the Geisel School of Medicine at Dartmouth. He completed his Internal Medicine Internship and Residency at the University of California, San Francisco, and fellowships in Infectious Diseases and Clinical Pharmacology at the Johns Hopkins University School of Medicine where he received his Ph.D. in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health. He also served in the Peace Corps in Ghana, West Africa. Dr. Ippolito specializes in global health and tropical infectious diseases with a research focus on malaria in sub-Saharan Africa. His NIH-supported research program explores the clinical pharmacology of antimalarial drugs and the genetic epidemiology of drug resistance. In his role as Director of Clinical Epidemiology for the Southern and Central Africa ICEMR, Dr. Ippolito designs and oversees clinical, translational, and epidemiological studies of malaria. Dr. Ippolito also serves as a Phase I and II clinical trialist for the LONGEVITY consortium, established to develop and deploy long-acting nanoformulations of essential anti-infective drugs. He is also a co-developer of a computer vision-based machine learning platform for malaria diagnostic and research applications, and serves on the editorial board of Frontiers in Malaria.

Shruti Makarand Paranjape MD, situated in Baltimore, MD, stands as a distinguished medical practice offering a seamless blend of superior patient care, cutting-edge medical training, and pioneering research initiatives. Boasting a network of top-tier hospitals, clinics, and medical facilities, they deliver a wide spectrum of healthcare solutions, from standard medical services to specialized treatments tailored to individual needs. With a strong emphasis on collaboration between medical experts and researchers, they drive forward the boundaries of medical discovery, elevating patient outcomes in diverse fields like cardiology, neurology, oncology, and pediatrics. Moreover, their unwavering commitment to education shines through in their meticulous training programs, shaping the future landscape of healthcare by nurturing the next generation of medical professionals and researchers. Through a steadfast dedication to scientific progress, cooperative patient care, and educational excellence, Shruti Makarand Paranjape MD continually upholds its esteemed reputation for advancing health and medical innovation, setting a high standard for comprehensive and compassionate medical services in the Baltimore area. Generated using this brand's available information